aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Free Cash Flow for the year ending December 31, 2023: USD -3.75 M

aap Implantate AG Free Cash Flow is USD -3.75 M for the year ending December 31, 2023, a -47.41% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

aap Implantate AG Free Cash Flow for the year ending December 31, 2022 was USD -2.54 M, a 25.32% change year over year.
aap Implantate AG Free Cash Flow for the year ending December 31, 2021 was USD -3.41 M, a 31.79% change year over year.
aap Implantate AG Free Cash Flow for the year ending December 31, 2020 was USD -4.99 M, a 40.30% change year over year.
aap Implantate AG Free Cash Flow for the year ending December 31, 2019 was USD -8.37 M, a 9.54% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years